Agricultural biotechnology, a pioneering field utilizing diverse scientific methods to alter plants' genetic composition, stands as the cornerstone of creating genetically modified organisms (GMOs). Its primary objective revolves around enhancing plants' resilience to diseases and harsh environmental conditions while concurrently boosting agricultural productivity. This technology's success hinges on the extensive cultivation of biotech crops globally and substantial investments in agricultural research and development endeavors. Nonetheless, its widespread acceptance encounters hurdles due to challenges associated with cultivating genetically engineered crops, particularly in Europe.
The agricultural biotechnology sector holds immense promise, with optimistic projections foreseeing a robust Compound Annual Growth Rate (CAGR) of 8.7%. By the conclusion of 2032, this market segment had already achieved an impressive valuation of USD 215.2 billion.
Agricultural biotechnology serves as a pioneering domain employing a spectrum of scientific methodologies aimed at modifying plants' genetic composition, ultimately resulting in the development of genetically modified organisms (GMOs). The fundamental objective is to fortify plants' ability to withstand diseases and harsh environmental conditions, all the while elevating agricultural productivity. The success of this technology heavily relies on the widespread cultivation of biotech crops across diverse regions and substantial investments poured into agricultural research and development initiatives. Nevertheless, its widespread adoption faces impediments, primarily due to challenges encountered in cultivating genetically engineered crops, particularly within the European landscape.
The Agricultural Biotechnology Market holds great potential, with optimistic forecasts pointing toward a robust Compound Annual Growth Rate (CAGR) of 8.7%. As of 2032, this market segment had already surged to an impressive valuation of USD 215.2 billion.
Agricultural biotechnology stands as the vanguard of employing varied scientific approaches to modify plants' genetic composition, thereby fostering the creation of genetically modified organisms (GMOs). Its chief objective revolves around enhancing plants' resilience against diseases and adverse environmental conditions, concurrently amplifying agricultural productivity. This technology's success pivots on the extensive cultivation of biotech crops globally and substantial investments directed into agricultural research and development endeavors. However, its widespread acceptance encounters obstacles primarily due to challenges associated with cultivating genetically engineered crops, particularly within the confines of Europe.
The Agricultural Biotechnology Market presents a promising outlook, with optimistic forecasts indicating a robust Compound Annual Growth Rate (CAGR) of 8.7%. By the culmination of 2032, this market segment had already attained an impressive valuation of USD 215.2 billion.
Covered Aspects:Report Attribute/Metric | Details |
---|---|
Growth Rate | 8.7% Base Year 2018 Forecast Period 2027 Historical Data 2017 Forecast Units Value (USD Million Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Crop Type, Application and Technique Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors Arcadia Biosciences (US)., Thermo Fisher Scientific (US), Bayer AG (Germany), Biocentury Transgene Co., Ltd (China), Vilmorin & Cie (France), Eurofins Scientific (Luxembourg), LGC Biosearch Technologies (US), Corteva Agriscience ( US), Dr. Chip Biotech Inc. (Taiwan), Evogene Ltd (Israel), and Yield10 Bioscience Key Market Opportunities Agriculture productivity Key Market Drivers· Adoption of biotech crops· High investment in agriculture research and development |
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)